These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 32978519)

  • 1. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M; Niu W; Zhang X; Hu S; Niu C
    Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling.
    Wang X; Li XD; Fu Z; Zhou Y; Huang X; Jiang X
    Int J Oncol; 2020 Feb; 56(2):508-521. PubMed ID: 31894297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
    Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAM87A as a Competing Endogenous RNA of miR-424-5p Suppresses Glioma Progression by Regulating PPM1H.
    Xu H; Zhang H; Tan L; Yang Y; Wang H; Zhao Q; Lu J
    Comput Math Methods Med; 2021; 2021():7952922. PubMed ID: 34712356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
    Cai H; Yu Y; Ni X; Li C; Hu Y; Wang J; Chen F; Xi S; Chen Z
    Cell Death Dis; 2020 Dec; 11(12):1032. PubMed ID: 33268783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway.
    Zhong X; Cai Y
    Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease: SOCS2-AS1/miR-324-5p/CUEDC2 axis regulates the progression of human umbilical vein endothelial cells.
    Zhao J; Chen D
    Pediatr Res; 2022 Aug; 92(2):388-395. PubMed ID: 32688371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma.
    Lu YF; Cai XL; Li ZZ; Lv J; Xiang YA; Chen JJ; Chen WJ; Sun WY; Liu XM; Chen JB
    Cell Physiol Biochem; 2018; 45(5):1975-1985. PubMed ID: 29529599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway.
    Zong Z; Song Y; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Cao S; Li Z; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):5048-5062. PubMed ID: 31207033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
    J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
    Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
    J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA nuclear enriched abundant transcript 1 impacts cell proliferation, invasion, and migration of glioma through regulating miR-139-5p/ CDK6.
    Wu DM; Wang S; Wen X; Han XR; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Zheng YL
    J Cell Physiol; 2019 May; 234(5):5972-5987. PubMed ID: 30515782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.
    Fan Z; Zheng J; Xue Y; Liu X; Wang D; Yang C; Ma J; Liu L; Ruan X; Wang Z; Liu Y
    Cell Death Dis; 2018 Dec; 9(12):1165. PubMed ID: 30518750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
    Ni W; Xia Y; Bi Y; Wen F; Hu D; Luo L
    Aging (Albany NY); 2019 Mar; 11(5):1427-1439. PubMed ID: 30860979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1.
    Li Y; Wang X; Zhao Z; Shang J; Li G; Zhang R
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33393590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
    Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.